Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Further Understanding of the Immunopathology of Multiple Sclerosis: Impact on Future Treatments.
Olfactory dysfunction in patients with multiple sclerosis.
Cortical functional modifications following optic neuritis.
A sensitive, noise-resistant method for identifying focal demyelination and remyelination in patients with multiple sclerosis via voxel-wise changes in magnetization transfer ratio.
Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study.
Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: application in multiple sclerosis.
Histamine and Immune Biomarkers in CNS Disorders.
Cross-disease transcriptomics: Unique IL-17A signaling in psoriasis lesions and an autoimmune PBMC signature.
Best Practices and Key Challenges in Cost-Effectiveness Modelling of Multiple Sclerosis Therapies.
NEDA status in highly active MS can be more easily obtained with autologous hematopoietic stem cell transplantation than other drugs.
Difficulties in adjustment to multiple sclerosis: vulnerability and unpredictability of illness in the foreground.
Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported.
Sunshine, Sea, and Season of Birth: MS Incidence in Wales.
Mucocele After Orbital Fracture Repair Masquerading as Optic Neuritis.
Quality of Life Among Patients with Multiple Sclerosis Treated with Prolonged-Release Fampridine 10 Mg Tablets for Walking Impairment.
Astrocyte tissue factor controls CNS hemostasis and autoimmune inflammation.
Pediatric Optic Neuritis Prospective Outcomes Study.
Co-stimulatory and Co-inhibitory Pathways in Autoimmunity.
Newly Identified Gait Patterns in Patient With Multiple Sclerosis May Be Related to Push-Off Quality.
Information processing speed in multiple sclerosis: Past, present, and future.
Financial and Clinical Implications of Intramuscular Versus Subcutaneous Interferon Beta-1a in Portugal, Based on the Findings from the Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis.
ERβ in CD4+ T Cells Is Crucial for Ligand-Mediated Suppression of Central Nervous System Autoimmunity.
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis.
Biotinidase deficiency mimicking neuromyelitis optica beginning at the age of 4: A treatable disease.
Systematic Review and Critique of Health Economic Models on Relapsing-Remitting Multiple Sclerosis in the UK.

Pages